Emcure Pharma IPO vs Sanstar IPO

Comparision between Emcure Pharma IPO and Sanstar IPO.

IPO Details

Emcure Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Sanstar IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Emcure Pharma IPO	Sanstar IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited	Pantomath Capital Advisors Pvt Ltd
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Emcure Pharma IPO is up to ₹1,952.03 Cr whereas the issue size of the Sanstar IPO is up to ₹510.15 Cr. The final issue price of Emcure Pharma IPO is ₹1,008.00 per share and of Sanstar IPO is ₹95.00 per share.

	Emcure Pharma IPO	Sanstar IPO
Face Value	₹10 per share	₹2 per share
Issue Price (Lower)	₹960.00 per share	₹90.00 per share
Issue Price (Upper)	₹1,008.00 per share	₹95.00 per share
Issue Price (Final)	₹1,008.00 per share	₹95.00 per share
Discount (Retail)
Discount (Employee)	₹90.00 per share
Market Lot Size	14 shares	150 shares
Fresh Issue Size	79,36,507 shares	4,18,00,000 shares
Fresh Issue Size (Amount)	up to ₹800.00 Cr	up to ₹397.10 Cr
OFS Issue Size	1,14,28,839 shares	1,19,00,000 shares
OFS Issue Size (Amount)	up to ₹1,152.03 Cr	up to ₹113.05 Cr
Issue Size Total	1,93,65,346 shares	5,37,00,000 shares
Issue Size Total (Amount)	up to ₹1,952.03 Cr	up to ₹510.15 Cr

IPO Timetable

Emcure Pharma IPO opens on Jul 03, 2024, while Sanstar IPO opens on Jul 19, 2024. The closing date of Emcure Pharma IPO and Sanstar IPO is Jul 05, 2024, and Jul 23, 2024, respectively.

	Emcure Pharma IPO	Sanstar IPO
Anchor Bid Date	Jul 02, 2024	Jul 18, 2024
Issue Open	Jul 03, 2024	Jul 19, 2024
Issue Close	Jul 05, 2024	Jul 23, 2024
Basis Of Allotment (Tentative)	Jul 08, 2024	Jul 24, 2024
Initiation of Refunds (Tentative)	Jul 09, 2024	Jul 25, 2024
Credit of Share (Tentative)	Jul 09, 2024	Jul 25, 2024
Listing date (Tentative)	Jul 10, 2024	Jul 26, 2024
Anchor Lockin End date 1	Aug 07, 2024	Aug 23, 2024
Anchor Lockin End date 2	Oct 06, 2024	Oct 22, 2024

Financials

Emcure Pharma IPO P/E ratio is 34.55, as compared to Sanstar IPO P/E ratio of 19.98.

Emcure Pharma IPO

Sanstar IPO

Financial

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,806.16	6,672.53	6,063.47
Revenue	6,715.24	6,031.72	5,918.86
Profit After Tax	527.58	561.85	702.56
Net Worth	2,952.28	2,501.13	1,987.55
Reserves and Surplus	2,722.40	2,293.77	1,791.03
Total Borrowing	2,091.94	2,202.42	2,102.19
Amount in ₹ Crore

Sanstar Limited Financial Information (Restated Consolidated)

Sanstar Limited's revenue decreased by -10.58% and profit after tax (PAT) rose by 59.71% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	527.57	368.35	207.45
Revenue	1,081.68	1,209.67	504.77
Profit After Tax	66.77	41.81	15.92
Net Worth	215.91	149.28	48.97
Reserves and Surplus	225.18	158.41	55.69
Total Borrowing	127.64	111.70	85.22
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

98.90%

99.77%

Promoter Shareholding (Post-Issue)

78.24%

70.37%

P/E Ratio

34.55

19.98

Market Cap

₹19029.89 Cr.

₹1731.32 Cr.

ROE

16.90%%

30.92%%

ROCE

19.37%%

24.43%%

Debt/Equity

0.67

0.5

EPS

₹29.17

₹4.75

RoNW

16.87%%

30.92%%

Shares Offered

In the Emcure Pharma IPO retail investors (RII) are offered 67,43,160 shares while in Sanstar IPO retail investors are offered 67,43,160 shares. Qualified institutional buyers (QIB) are offered 38,53,234 shares in Emcure Pharma IPO and 1,07,40,000 shares in Sanstar IPO.

	Emcure Pharma IPO	Sanstar IPO
Anchor Investor Reserveration	57,79,850 shares	1,61,10,000 shares
Market Maker Reserveration
QIB	38,53,234 shares	1,07,40,000 shares
NII	28,89,926 shares	80,55,000 shares
RII	67,43,160 shares	1,87,95,000 shares
Employee	1,08,900 shares	0 shares
Others
Total	1,37,03,538 shares	3,75,90,000 shares

Bids Received (Subscription)

Emcure Pharma IPO subscribed 67.87x in total, whereas Sanstar IPO subscribed 82.99x.

	Emcure Pharma IPO	Sanstar IPO
QIB (times)	191.24x	145.68x
NII (times)	49.32x	136.49x
Big NII (times)	54.90x	149.44x
Small NII (times)	38.16x	110.61x
RII (times)	7.36x	24.23x
Employee (times)	8.81x
Other (times)
Total (times)	67.87x	82.99x

Compare with others

Emcure Pharma IPO	Sanstar IPO
Akums Drugs and Pharmaceuticals IPO	Akums Drugs and Pharmaceuticals IPO
Sanstar IPO	Bansal Wire IPO
Bansal Wire IPO	Emcure Pharma IPO
OLA Electric	OLA Electric
Vraj Iron and Steel IPO	Vraj Iron and Steel IPO
Aasaan Loans IPO	Aasaan Loans IPO
Stanley Lifestyles IPO
DEE Piping Systems IPO

Comments

Add a public comment...